Advertisement
UK markets close in 5 hours 59 minutes
  • FTSE 100

    7,857.69
    -107.84 (-1.35%)
     
  • FTSE 250

    19,413.09
    -285.80 (-1.45%)
     
  • AIM

    741.34
    -8.94 (-1.19%)
     
  • GBP/EUR

    1.1714
    +0.0004 (+0.03%)
     
  • GBP/USD

    1.2444
    -0.0002 (-0.02%)
     
  • Bitcoin GBP

    51,058.08
    -2,559.63 (-4.77%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,061.82
    -61.59 (-1.20%)
     
  • DOW

    37,735.11
    -248.13 (-0.65%)
     
  • CRUDE OIL

    85.18
    -0.23 (-0.27%)
     
  • GOLD FUTURES

    2,386.00
    +3.00 (+0.13%)
     
  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     
  • HANG SENG

    16,248.97
    -351.49 (-2.12%)
     
  • DAX

    17,768.25
    -258.33 (-1.43%)
     
  • CAC 40

    7,941.82
    -103.29 (-1.28%)
     

It's a Bear Market, but Is This Stock in Even More Trouble?

It's a Bear Market, but Is This Stock in Even More Trouble?

Indeed, the S&P 500 is in bear market territory, defined as a 20% (or more) drop from its most recent high. Take biotech company Novavax (NASDAQ: NVAX). While the broader market sell-off hasn't helped Novavax, the company has encountered its own issues, too.